Application of lung volume reduction surgery for a child with filamin A (FLNA) mutations.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8510590 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1099-0496 (Electronic) Linking ISSN: 10990496 NLM ISO Abbreviation: Pediatr Pulmonol Subsets: MEDLINE
    • Publication Information:
      Publication: <2005-> : Hoboken, NJ : Wiley-Liss
      Original Publication: [Philadelphia, PA] : W.B. Saunders, [c1985-
    • Subject Terms:
    • Abstract:
      Diffuse lung disease in early childhood due to mutations in the filamin A gene has been recently reported. Clinical outcomes vary among individuals indicating variability in phenotype but a substantial proportion of reported cases in early life have ended up in death or lung transplantation. We recently encountered a school-aged child in whom the diagnosis of a filamin A mutation was delayed and the natural history of emphysematous lung disease was altered by serial lung volume reduction surgeries. She eventually underwent a bilateral lung transplant and we report the natural history of her disease and treatments applied herein.
      (© 2021 Wiley Periodicals LLC.)
    • References:
      Fox JW, Lamperti ED, Ekşioğlu YZ, et al. Mutations in filamin 1 prevent migration of cerebral cortical neurons in human periventricular heterotopia. Neuron. 1998;21:1315-1325.
      Taylor PA, Dishop MK, Lotze TE, Mallory GB, Guillerman RP. Congenital multilobar emphysema, a characteristic lung growth disorder attributable to filamin A gene mutations. Pediatr Radiol. 2009;39(Suppl 3):S516.
      de Wit MC, Tiddens HA, de Coo IF, Mancini GM. Lung disease in FLNA mutation: confirmatory report. Eur J Med Genet. 2011;54:299-300.
      Burrage LC, Guillerman RP, Das S, et al. Lung transplantation for FLNA-associated progressive lung disease. J Pediatr. 2017;186:118-123.
      Shelmerdine SC, Semple T, Wallis C, et al. Filamin A (FLNA) mutation-a newcomer to the childhood interstitial lung disease (ChILD) classification. Pediatr Pulmonol. 2017;52:1306-1315.
      Sasaki E, Byrne AT, Phelan E, Cox DW, Reardon W. A review of filamin A mutations and associated lung disease. Eur J Pediatr. 2019;178:121-129.
      Pelizzo G, Collura M, Puglisi A, et al. Congenital emphysematous lung disease associated with a novel filamin A mutation. Case report and literature review. BMC Pediatr. 2019;19:86. https://doi.org/10.1186/s12887-019-1460-4.
      Yoshi K, Matsumoto H, Hirasawa K, et al. Microdeletion in Xq28 with a polymorphic inversion in a patient with FLNA-associated progressive lung disease. Respir Investig. 2019;57(4):395-398.
      Masurel-Paulet A, Haan E, Thompson EM, et al. Lung disease associated with periventricular nodular heterotopia and an FLNA mutation. Eur J Med Genet. 2011;54:25-28.
      Lange M, Kasper B, Bohring A, et al. 47 patients with FLNA associated periventricular heterotopia. Orphanet J Rare Dis. 2015;10:134. https://doi.org/10.1186/s13023-015-0331-9.
      Kremer TM, Lindsay ME, Kinane TB, Hawley MH, Little BP, Mino-Kenudson M. Case 28-2019: a 22-year-old woman with dyspnea and chest pain. N Engl J Med. 2019;381:1059-1067.
      Fox JW, Lamperti ED, Ekşioğlu YZ, et al. Mutations in filamin 1 prevent migration of cerebral cortical neurons in human periventricular heterotopia. Neuron. 1998;21:1315-1325.
      Lord A, Shapiro AJ, Saint-Martin C, Claveau M, Melancon S, Wintermark P. Filamin A mutation may be associated with diffuse lung disease mimicking bronchopulmonary dysplasia in premature newborns. Respir Care. 2014;59:e171-e177.
      de Wit MCY, de Coo IFM, Lequin MH, Halley DJJ, Roos-Hesselink JW, Mancini GMS. Combined cardiological and neurological abnormalities due to filamin A gene mutation. Clin Res Cardiol. 2011;100:45-50.
      Calcaterra VM, Avanzini MA, Mantelli M, et al. A case report on filamin A gene mutation and progressive pulmonary disease in an infant: a lung tissue derived mesenchymal stem cell study. Medicine. 2018;97:e13033. https://doi.org/10.1097/MD.0000000000013033.
      Pelizzo G, Avanzini MA, Lenta E, et al. Allogenic mesenchymal stromal cells: novel therapeutic option for mutated FLNA-associated respiratory failure in the pediatric setting. Pediatr Pulmonol. 2019;55:190-197. https://doi.org/10.1002/ppul.24497.
      Siaplaouras J, Heckmann M, Reiss I, Schaible T, Waag KL, Gortner L. Lung volume reduction surgery in bronchopulmonary dysplasia. Acta Paediatr. 2003;92:754-756.
      De Laffolie J, Hirschburger M, Bauer J, Berthold LD, Faas D, Heckmann M. Lung volume reduction surgery in preterm infants with bronchopulmonary dysplasia. A case report. Clin Case Rep. 2013;1:96-99.
      Sohn B, Park S, Park IK, et al. Lung volume reduction surgery for respiratory failure in infants with bronchopulmonary dysplasia. Pediatr. 2018;141:S395-S398.
      Julian V, de Bellaing AM, Filaire M, Richard R, Labbe A. Functional benefits of bilateral emphysema reduction surgery in an adolescent. Ann Thorac Surg. 2016;102:e195-e196.
    • Contributed Indexing:
      Keywords: filamin A mutation; genetics/genome-; interstitial lung disease (ILD); lung transplantation; lung volume reduction surgery; wide association studies (GWAS)
    • Accession Number:
      0 (FLNA protein, human)
      0 (Filamins)
    • Publication Date:
      Date Created: 20211209 Date Completed: 20220103 Latest Revision: 20220531
    • Publication Date:
      20221213
    • Accession Number:
      10.1002/ppul.25681
    • Accession Number:
      34882997